CBD Life Sciences Inc.
CBDL
$0.0004
$0.000.00%
03/31/2024 | 03/31/2023 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 100.00 | 600.00 | 1.03M | 1.03M | 1.03M |
Total Receivables | 176.00K | -- | -- | -- | -- |
Inventory | 9.20K | -- | -- | 46.10K | 46.10K |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 185.30K | -- | -- | 1.07M | 1.07M |
|
|||||
Total Current Assets | 185.30K | -- | -- | 1.07M | 1.07M |
Net Property, Plant & Equipment | 74.50K | -- | -- | 185.80K | 185.80K |
Long-term Investments | 100.00K | -- | -- | 100.00K | 100.00K |
Goodwill | 100.00K | -- | -- | 100.00K | 100.00K |
Total Other Intangibles | 22.10K | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 4.90K | -- | -- | 4.90K | 4.90K |
Total Assets | 386.70K | -- | -- | 1.36M | 1.36M |
|
|||||
Total Accounts Payable | -- | -- | -- | -- | -- |
Total Accrued Expenses | 20.00K | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 24.60K | -- | -- | -- | -- |
Total Other Current Liabilities | 24.60K | -- | -- | -- | -- |
Total Current Liabilities | 44.50K | -- | -- | -- | -- |
|
|||||
Total Current Liabilities | 44.50K | -- | -- | -- | -- |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | 30.40K | 30.40K |
Total Liabilities | 44.50K | -- | -- | 30.40K | 30.40K |
|
|||||
Common Stock & APIC | 14.89M | -- | -- | 14.89M | 14.89M |
Retained Earnings | -14.61M | -- | -- | -13.62M | -13.62M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 276.10K | 68.40K | 1.27M | 1.27M | 1.27M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | 66.10K | -- | -- | 66.10K | 66.10K |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 66.10K | 66.10K | 66.10K | 66.10K | 66.10K |
|
|||||
Total Common Equity | 276.10K | 68.40K | 1.27M | 1.27M | 1.27M |
Total Preferred Equity | 66.10K | 66.10K | 66.10K | 66.10K | 66.10K |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 342.20K | 134.50K | 1.33M | 1.33M | 1.33M |
|